Principal Financial Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6M Sell
1,547,662
-608,504
-28% -$8.04M 0.01% 910
2026
Q1
$29.7M Buy
2,156,166
+545,334
+34% +$8.22M 0.02% 693
2025
Q4
$29M Sell
1,610,832
-46,880
-3% -$842K 0.01% 682
2025
Q3
$30.7M Buy
1,657,712
+346,855
+26% +$5.45M 0.02% 647
2025
Q2
$21M Buy
1,310,857
+258,392
+25% +$4.61M 0.01% 816
2025
Q1
$20.4M Sell
1,052,465
-2,523
-0.2% -$53.1K 0.01% 816
2024
Q4
$23.2M Sell
1,054,988
-334,666
-24% -$6.44M 0.01% 765
2024
Q3
$23.4M Buy
+1,389,654
New +$20.6M 0.01% 757

Other funds holding CLBT

Principal Financial Group's CLBT Position: Q2 2026 in Review

Principal Financial Group reduced its Cellebrite (CLBT) stake by 28% in Q2 2026, selling an estimated $8.04M and leaving 1,547,662 shares worth $22.6M. The position accounts for 0.01% of the portfolio, ranked #910.

Principal Financial Group first reported a position in CLBT in Q3 2024 and has held it in 8 quarters since. The position peaked at $30.7M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Principal Financial Group held 1,547,662 shares of Cellebrite worth $22.6M as of Q2 2026.
  • Principal Financial Group sold 608,504 Cellebrite shares in Q2 2026, an estimated $8.04M.
  • Cellebrite made up 0.01% of Principal Financial Group's portfolio in Q2 2026, its #910 holding.
  • Principal Financial Group first reported a position in Cellebrite in Q3 2024 and has held it in 8 quarters since.
  • Principal Financial Group's Cellebrite position peaked at $30.7M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.